Optiver Holding
INBX icon

Optiver Holding’s Inhibrx INBX Stock Holding History

Optiver Holding’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.7K Buy
962
+30
+3% +$2.23K ﹤0.01% 925
2025
Q4 		$73.6K Buy
932
+818
+718% +$55.7K ﹤0.01% 855
2025
Q3 		$3.84K Buy
+114
New +$2.81K ﹤0.01% 1986

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Optiver Holding's INBX Position: Q1 2026 in Review

Optiver Holding increased its Inhibrx (INBX) stake by 3.2% in Q1 2026, buying an estimated $2.23K and bringing the position to 962 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Optiver Holding first reported a position in INBX in Q3 2025 and has held it in 3 quarters since. The position peaked at $73.6K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Optiver Holding held 962 shares of Inhibrx worth $64.7K as of Q1 2026.
  • Optiver Holding bought 30 Inhibrx shares in Q1 2026, an estimated $2.23K.
  • Inhibrx made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #925 holding.
  • Optiver Holding first reported a position in Inhibrx in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Inhibrx position peaked at $73.6K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.